Flora Growth Forms JV With Avaria Health and Beauty to Distribute Award-Winning Pain Products Across LATAM
Retrieved on:
Friday, November 26, 2021
Other Health, Men, General Health, Discount, Variety, Specialty, Consumer, Convenience Store, Retail, Other Consumer, Women, Alternative Medicine, Health, Volunteering, Patient, Research, Sale, CEO, Environment, Technology, Industry, Forward-looking statement, Cannabis, Company, Arthralgia, IPO, FLGC, Tendinopathy, Nature, Pain, Kalaya, Emulsion, Flora, Oil, NASDAQ, Cannabidiol, Arthritis, Terminology, LATAM, Gel, Food, Growth, Cosmetics, Drug, Pharmaceutical industry, Risk management, Flora Growth’s Recent Financing, Avaria Health & Beauty Corp., Flora Growth Corp., FLORA GROWTH’S RECENT FINANCING, AVARIA HEALTH & BEAUTY CORP., FLORA GROWTH CORP.
Any profits from the sale of KaLaya products via FloVaria will be divided equally between Flora and Avaria, increasing the value of Floras existing distribution channels.
Key Points:
- Any profits from the sale of KaLaya products via FloVaria will be divided equally between Flora and Avaria, increasing the value of Floras existing distribution channels.
- Further, Flora Lab will work to produce FloVarias cannabinoid-infused products, with an emphasis on incorporating cannabidiol (CBD), using cannabis from Floras cultivation facility.
- Avaria has achieved impressive and continued growth of its KaLaya brand based on the quality and efficacy of the product.
- Our team is very excited to bring their award-winning topical pain products to our LATAM distribution network, and to produce cannabinoid-infused KaLaya products at Flora Lab.